The post is funded by a Health Research Award to Dr Maura Grealy and Dr Lucy Byrnes. The work will involve collaboration with Prof Peter Dockery, Anatomy, School of Medicine and Prof Didier Stainier, Department of Biochemistry and Biophysics, University of California, San Francisco.

Essential Qualifications: Applicants must have completed a PhD in molecular, cellular or developmental biology, with a good publication record and have a keen interest in pursuing research in heart development. The successful applicant will have expertise in molecular techniques and be experienced in both independent and collaborative research.  Excellent oral communication and interpersonal skills are required.

Desirable Qualifications: The ideal candidates will have significant experience in one or more of the following: zebrafish embryo microinjection, western blotting, confocal microscopy, q RTPCR, immunohistochemistry; peer-reviewed publications in areas of relevance to the project are also desirable.

Start date: October 2011

Starting salary:  €41,181 per annum

Informal enquiries by e-mail to: Dr Maura Grealy, Pharmacology and Therapeutics, School of Medicine. Email: maura.grealy@nuigalway.ie

To apply: Candidates should send a detailed curriculum vitae with a covering letter (Word or PDF format only)  explaining their interest in the post and the names and contact details of at least three and not more than five referees by e-mail to: maura.grealy@nuigalway.ie

Please ensure to put the reference number NUIG-63-11 in the subject line of the email application.

Closing date for receipt of applications is 5.00 p.m. Friday 17th September 2011.

National University of Ireland, Galway is an equal opportunities employer.